Analysis and Commentary STEVEN GROSSMAN 3/31/17 Analysis and Commentary STEVEN GROSSMAN 3/31/17 President Trump's FY 18 Proposed Budget: More Qs and More As Read More Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More Analysis and Commentary STEVEN GROSSMAN 3/24/17 Analysis and Commentary STEVEN GROSSMAN 3/24/17 Ag/FDA Appropriations Subcommittees Need to Hear From Entire Stakeholder Community Read More Advocacy at a Glance STEVEN GROSSMAN 3/24/17 Advocacy at a Glance STEVEN GROSSMAN 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More Analysis and Commentary STEVEN GROSSMAN 3/17/17 Analysis and Commentary STEVEN GROSSMAN 3/17/17 President Trump's FY 18 Proposed Budget: Some Qs and Some As Read More Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Alliance Responds to the President’s Proposals and more Read More STEVEN GROSSMAN 3/16/17 STEVEN GROSSMAN 3/16/17 Statement of the Alliance on Today's OMB Budget Release Read More Analysis and Commentary STEVEN GROSSMAN 3/11/17 Analysis and Commentary STEVEN GROSSMAN 3/11/17 From "Hibernation" to Avoidance of Confusion Read More Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Trump to Release Outline of His Budget Requests and more Read More Analysis and Commentary STEVEN GROSSMAN 3/3/17 Analysis and Commentary STEVEN GROSSMAN 3/3/17 Guns, Butter, and the Uniqueness of the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 3/3/17 Advocacy at a Glance STEVEN GROSSMAN 3/3/17 FDA Stakeholders Should Be Very Concerned, But Not Panicked Read More Analysis and Commentary STEVEN GROSSMAN 2/24/17 Analysis and Commentary STEVEN GROSSMAN 2/24/17 There Is No Secret Plan ... And No "Secret Sauce" Either! Read More Advocacy at a Glance STEVEN GROSSMAN 2/24/17 Advocacy at a Glance STEVEN GROSSMAN 2/24/17 HHS Secretary Price Tours FDA and more Read More STEVEN GROSSMAN 2/18/17 STEVEN GROSSMAN 2/18/17 The Alliance Sets It's "Ask" for FY 18 Read More Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Uncertain Effects on FDA of Hiring Freeze and more Read More Analysis and Commentary STEVEN GROSSMAN 2/13/17 Analysis and Commentary STEVEN GROSSMAN 2/13/17 Strong Leadership on Resources Essential Read More Advocacy at a Glance STEVEN GROSSMAN 2/13/17 Advocacy at a Glance STEVEN GROSSMAN 2/13/17 FDA’s Status Uncertain Read More Analysis and Commentary STEVEN GROSSMAN 2/3/17 Analysis and Commentary STEVEN GROSSMAN 2/3/17 One Size Still Does Not Fit All Read More Advocacy at a Glance STEVEN GROSSMAN 2/3/17 Advocacy at a Glance STEVEN GROSSMAN 2/3/17 OMB Clarifies Some Details on the President’s Federal Hiring Freeze and more Read More Analysis and Commentary STEVEN GROSSMAN 1/27/17 Analysis and Commentary STEVEN GROSSMAN 1/27/17 The Ramifications of the Federal Hiring Freeze Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 3/31/17 Analysis and Commentary STEVEN GROSSMAN 3/31/17 President Trump's FY 18 Proposed Budget: More Qs and More As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/24/17 Analysis and Commentary STEVEN GROSSMAN 3/24/17 Ag/FDA Appropriations Subcommittees Need to Hear From Entire Stakeholder Community Read More
Advocacy at a Glance STEVEN GROSSMAN 3/24/17 Advocacy at a Glance STEVEN GROSSMAN 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/17/17 Analysis and Commentary STEVEN GROSSMAN 3/17/17 President Trump's FY 18 Proposed Budget: Some Qs and Some As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Alliance Responds to the President’s Proposals and more Read More
STEVEN GROSSMAN 3/16/17 STEVEN GROSSMAN 3/16/17 Statement of the Alliance on Today's OMB Budget Release Read More
Analysis and Commentary STEVEN GROSSMAN 3/11/17 Analysis and Commentary STEVEN GROSSMAN 3/11/17 From "Hibernation" to Avoidance of Confusion Read More
Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Trump to Release Outline of His Budget Requests and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/3/17 Analysis and Commentary STEVEN GROSSMAN 3/3/17 Guns, Butter, and the Uniqueness of the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 3/3/17 Advocacy at a Glance STEVEN GROSSMAN 3/3/17 FDA Stakeholders Should Be Very Concerned, But Not Panicked Read More
Analysis and Commentary STEVEN GROSSMAN 2/24/17 Analysis and Commentary STEVEN GROSSMAN 2/24/17 There Is No Secret Plan ... And No "Secret Sauce" Either! Read More
Advocacy at a Glance STEVEN GROSSMAN 2/24/17 Advocacy at a Glance STEVEN GROSSMAN 2/24/17 HHS Secretary Price Tours FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Uncertain Effects on FDA of Hiring Freeze and more Read More
Analysis and Commentary STEVEN GROSSMAN 2/13/17 Analysis and Commentary STEVEN GROSSMAN 2/13/17 Strong Leadership on Resources Essential Read More
Advocacy at a Glance STEVEN GROSSMAN 2/13/17 Advocacy at a Glance STEVEN GROSSMAN 2/13/17 FDA’s Status Uncertain Read More
Analysis and Commentary STEVEN GROSSMAN 2/3/17 Analysis and Commentary STEVEN GROSSMAN 2/3/17 One Size Still Does Not Fit All Read More
Advocacy at a Glance STEVEN GROSSMAN 2/3/17 Advocacy at a Glance STEVEN GROSSMAN 2/3/17 OMB Clarifies Some Details on the President’s Federal Hiring Freeze and more Read More
Analysis and Commentary STEVEN GROSSMAN 1/27/17 Analysis and Commentary STEVEN GROSSMAN 1/27/17 The Ramifications of the Federal Hiring Freeze Read More
